Market Overview:
The global swine vaccines market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising demand for pork, increasing awareness about animal health and diseases, and technological advancements in the field of swine vaccines. Based on type, the global swine vaccines market is segmented into CSF vaccines, FMD vaccines, porcine circovirus (PCV) vaccines, PRRS (porcine reproductive and respiratory syndrome) viruses vaccine and other types of vaccine. The CSF (contagious bovine pleuropneumonia) vaccine segment is expected to account for a major share of the global market due to high prevalence of this disease in cattle population across different regions. However, PCV vaccine segment is projected to grow at highest CAGR during forecast period owing increase in demand for these types of vaccination globally.
Product Definition:
Swine vaccines are a class of vaccine used to prevent diseases in pigs. They are generally administered by injection. Vaccination is an important part of managing swine health, and helps reduce the incidence of disease, which can lead to increased production and reduced mortality.
CSF Vaccines:
A cerebrospinal fluid (CSF) vaccine is a vaccine designed to stimulate the body's immune system in order to prevent or reduce a neurological disease. The most common symptoms of CSF vaccines include stiff neck, head pain, nausea and vomiting among others. According to the National Center for Biotechnology Information (NCBI), around 10% of people suffering from multiple sclerosis are asymptomatic or have mild symptoms that do not impede their daily activities.
FMD Vaccines:
FMD vaccines are used in swine or pig vaccines. It is a live attenuated vaccine, which is developed to protect pigs from foot and mouth disease, also known as swine flu. The vaccine consists of an infectious virus that can cause the fatal disease among pigs if not treated at the right time. FMD (foot and mouth) diseases are highly contagious and can affect all types of domestic animals including dogs, cats, sheep/woolens etc.
Application Insights:
The market is segmented by application into government tender, market sales and others. The government tender segment held the largest share in 2017 owing to increased spending on Swine Flu Immunization Program (SFI) for pigs. Market sales are anticipated to be the fastest-growing application over the forecast period due to high product demand from commercial piggeries and backyard farms.
PRRS is a significant disease threat among sows that results in reduced litter size and early weaning of piglets. Thus, vaccination against PRRS offers higher value for money as compared with other diseases caused due to circovirus or influenza A viruses as it protects against not only these two but also against Newcastle Disease which causes mortality rate of 50% among young pigs along with economic losses worth tens of thousands of dollars per outbreak.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to high awareness levels about swine health and strong government support for vaccination programs. In addition, increasing demand for pork products coupled with growing consumption of processed meat such as ham, bacon and sausages is anticipated to drive growth over the forecast period.
Asia Pacific market was valued at USD X billion in 2017 owing to rising demand from developing countries such as China and India that are majorly populated by pigskin consumers like Japan, Australia, Philippines etc., thus making it a lucrative regional market for vaccine manufacturers over the next eight years.
In addition there has been an increase in investment by foreign players especially those based out of U.S.
Growth Factors:
- Increasing demand for pork products due to changing dietary preferences of consumers in developing countries.
- Rising awareness about the benefits of vaccination among pig farmers and veterinarians.
- Growing number of outbreaks of swine diseases that has led to increased demand for vaccines worldwide.
- Technological advancements in vaccine development and production processes that are helping to reduce the cost of vaccines.
Scope Of The Report
Report Attributes
Report Details
Report Title
Swine Vaccines Market Research Report
By Type
CSF Vaccines, FMD Vaccines, Porcine Circovirus Vaccines, PRRS Vaccines, Other
By Application
Government Tender, Market Sales
By Companies
Merck, Boehringer Ingelheim, Jinyu Bio-Technology, CAHIC, Tecon, Zoetis, Ceva, Hile Bio, Chopper Biology, WINSUN, Hipra, Ringpu Biology, ChengDu Tecbond, DHN, CAVAC, Virbac, HVRI, Bioveta
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Swine Vaccines Market Report Segments:
The global Swine Vaccines market is segmented on the basis of:
Types
CSF Vaccines, FMD Vaccines, Porcine Circovirus Vaccines, PRRS Vaccines, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Government Tender, Market Sales
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck
- Boehringer Ingelheim
- Jinyu Bio-Technology
- CAHIC
- Tecon
- Zoetis
- Ceva
- Hile Bio
- Chopper Biology
- WINSUN
- Hipra
- Ringpu Biology
- ChengDu Tecbond
- DHN
- CAVAC
- Virbac
- HVRI
- Bioveta
Highlights of The Swine Vaccines Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- CSF Vaccines
- FMD Vaccines
- Porcine Circovirus Vaccines
- PRRS Vaccines
- Other
- By Application:
- Government Tender
- Market Sales
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Swine Vaccines Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Swine vaccines are a type of vaccine that is used to protect pigs from diseases. Swine vaccines can help prevent diseases such as porcine epidemic diarrhea, hog cholera, and Newcastle disease.
Some of the major players in the swine vaccines market are Merck, Boehringer Ingelheim, Jinyu Bio-Technology, CAHIC, Tecon, Zoetis, Ceva, Hile Bio, Chopper Biology, WINSUN, Hipra, Ringpu Biology, ChengDu Tecbond, DHN, CAVAC, Virbac, HVRI, Bioveta.
The swine vaccines market is expected to grow at a compound annual growth rate of 6.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Swine Vaccines Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Swine Vaccines Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Swine Vaccines Market - Supply Chain
4.5. Global Swine Vaccines Market Forecast
4.5.1. Swine Vaccines Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Swine Vaccines Market Size (000 Units) and Y-o-Y Growth
4.5.3. Swine Vaccines Market Absolute $ Opportunity
5. Global Swine Vaccines Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Swine Vaccines Market Size and Volume Forecast by Type
5.3.1. CSF Vaccines
5.3.2. FMD Vaccines
5.3.3. Porcine Circovirus Vaccines
5.3.4. PRRS Vaccines
5.3.5. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Swine Vaccines Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Swine Vaccines Market Size and Volume Forecast by Application
6.3.1. Government Tender
6.3.2. Market Sales
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Swine Vaccines Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Swine Vaccines Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Swine Vaccines Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Swine Vaccines Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Swine Vaccines Demand Share Forecast, 2019-2026
9. North America Swine Vaccines Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Swine Vaccines Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Swine Vaccines Market Size and Volume Forecast by Application
9.4.1. Government Tender
9.4.2. Market Sales
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Swine Vaccines Market Size and Volume Forecast by Type
9.7.1. CSF Vaccines
9.7.2. FMD Vaccines
9.7.3. Porcine Circovirus Vaccines
9.7.4. PRRS Vaccines
9.7.5. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Swine Vaccines Demand Share Forecast, 2019-2026
10. Latin America Swine Vaccines Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Swine Vaccines Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Swine Vaccines Market Size and Volume Forecast by Application
10.4.1. Government Tender
10.4.2. Market Sales
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Swine Vaccines Market Size and Volume Forecast by Type
10.7.1. CSF Vaccines
10.7.2. FMD Vaccines
10.7.3. Porcine Circovirus Vaccines
10.7.4. PRRS Vaccines
10.7.5. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Swine Vaccines Demand Share Forecast, 2019-2026
11. Europe Swine Vaccines Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Swine Vaccines Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Swine Vaccines Market Size and Volume Forecast by Application
11.4.1. Government Tender
11.4.2. Market Sales
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Swine Vaccines Market Size and Volume Forecast by Type
11.7.1. CSF Vaccines
11.7.2. FMD Vaccines
11.7.3. Porcine Circovirus Vaccines
11.7.4. PRRS Vaccines
11.7.5. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-YGrowth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Swine Vaccines Demand Share, 2019-2026
12. Asia Pacific Swine Vaccines Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Swine Vaccines Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Swine Vaccines Market Size and Volume Forecast by Application
12.4.1. Government Tender
12.4.2. Market Sales
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Swine Vaccines Market Size and Volume Forecast by Type
12.7.1. CSF Vaccines
12.7.2. FMD Vaccines
12.7.3. Porcine Circovirus Vaccines
12.7.4. PRRS Vaccines
12.7.5. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Swine Vaccines Demand Share, 2019-2026
13. Middle East & Africa Swine Vaccines Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Swine Vaccines Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Swine Vaccines Market Size and Volume Forecast by Application
13.4.1. Government Tender
13.4.2. Market Sales
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Swine Vaccines Market Size and Volume Forecast by Type
13.7.1. CSF Vaccines
13.7.2. FMD Vaccines
13.7.3. Porcine Circovirus Vaccines
13.7.4. PRRS Vaccines
13.7.5. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Swine Vaccines Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Swine Vaccines Market: Market Share Analysis
14.2. Swine Vaccines Distributors and Customers
14.3. Swine Vaccines Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Merck
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Boehringer Ingelheim
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Jinyu Bio-Technology
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. CAHIC
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Tecon
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Zoetis
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Ceva
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Hile Bio
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Chopper Biology
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. WINSUN
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Hipra
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Ringpu Biology
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. ChengDu Tecbond
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. DHN
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. CAVAC
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Virbac
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. HVRI
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. Bioveta
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook